title: Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
abstract: Tuberous sclerosis complex (TSC), an autosomal dominant disease caused by mutations in either TSC1 or TSC2, is characterized by the development of hamartomas in a variety of organs. Concordant with the tumor-suppressor model, loss of heterozygosity (LOH) is known to occur in these hamartomas at loci of both TSC1 and TSC2. LOH has been documented in renal angiomyolipomas (AMLs), but loss of the wild-type allele in cortical tubers appears to be very uncommon. Analysis of second, somatic events in tumors for which the status of both TSC1 and TSC2 is known is essential for exploration of the pathogenesis of TSC-lesion development. We analyzed 24 hamartomas from 10 patients for second-hit mutations, by several methods, including LOH, scanning of all exons of both TSC1 and TSC2, promoter methylation of TSC2, and clonality analysis. Our results document loss of the wild-type allele in six of seven AMLs, without evidence of the inactivation of the second allele in many of the other lesions, including tumors that appear to be clonally derived. Laser-capture microdissection further demonstrated loss of the second allele in all three cellular components of an AML. This study thus provides evidence that, in both TSC1 and TSC2, somatic mutations resulting in the loss of wild-type alleles may not be necessary in some tumor types-and that other mechanisms may contribute to tumorigenesis in this setting.
authors.affiliation: Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Niida
authors.forename: A O
authors.initials: AO
authors.lastname: Stemmer-Rachamimov
authors.forename: M
authors.initials: M
authors.lastname: Logrip
authors.forename: D
authors.initials: D
authors.lastname: Tapon
authors.forename: R
authors.initials: R
authors.lastname: Perez
authors.forename: D J
authors.initials: DJ
authors.lastname: Kwiatkowski
authors.forename: K
authors.initials: K
authors.lastname: Sims
authors.forename: M
authors.initials: M
authors.lastname: MacCollin
authors.forename: D N
authors.initials: DN
authors.lastname: Louis
authors.forename: V
authors.initials: V
authors.lastname: Ramesh
mesh_terms: D002999:Clone Cells; D018095:Germ-Line Mutation; D006222:Hamartoma / Q000235:genetics*; D006801:Humans; D019656:Loss of Heterozygosity; D008969:Molecular Sequence Data; D011506:Proteins / Q000235:genetics*; D012097:Repressor Proteins / Q000235:genetics; D014402:Tuberous Sclerosis / Q000235:genetics*; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins
chemical_list: D011506:Proteins; D012097:Repressor Proteins; C000624650:TSC1 protein, human; C000624653:TSC2 protein, human; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins